XEOMIN (NT-201) Receives FDA Approval for Therapeutic Treatments
Merz Pharmaceutical seems poised to become a leader in the U.S. as a provider of aesthetic medicine. Yesterday the company announced FDA approval for NT-201, a drug now known as XEOMIN. Along with the relatively new Dysport and popular Botox®, it’s the 3rd botulinum toxin to receive FDA approval for treating cervical dystonia and...
View More